0001415889-23-014632.txt : 20231031 0001415889-23-014632.hdr.sgml : 20231031 20231031172012 ACCESSION NUMBER: 0001415889-23-014632 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231027 FILED AS OF DATE: 20231031 DATE AS OF CHANGE: 20231031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lucsok Anna CENTRAL INDEX KEY: 0001843904 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38804 FILM NUMBER: 231365768 MAIL ADDRESS: STREET 1: 9555 MAROON CIRCLE CITY: ENGLEWOOD STATE: CO ZIP: 80112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZYNEX INC CENTRAL INDEX KEY: 0000846475 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 870403828 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9655 MAROON CIRCLE CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: (800)-495-6670 MAIL ADDRESS: STREET 1: 9655 MAROON CIRCLE CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20050812 FORMER COMPANY: FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20040120 FORMER COMPANY: FORMER CONFORMED NAME: FOX RIVER HOLDINGS INC DATE OF NAME CHANGE: 20031126 4 1 form4-10312023_051001.xml X0508 4 2023-10-27 0000846475 ZYNEX INC ZYXI 0001843904 Lucsok Anna 9655 MAROON CIRCLE ENGLEWOOD CO 80112 false true false false CHIEF OPERATING OFFICER 0 Common Stock (Restricted Stock Award) 2023-10-27 4 A 0 5000 0 A 85952 D Common Stock (Restricted Stock Award) 2023-10-27 4 A 0 3671 0 A 89623 D Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the "Plan") pursuant to which the 5,000 shares vest equally, on an annual basis, over a period of four years beginning one year from the grant date. Represents restricted stock awards under the Plan, which have not vested. Represents a restricted stock award issued pursuant to the Issuer's 2017 Stock Incentive Plan (the "Plan") pursuant to which the 3,671 shares vest equally, on a quarterly basis, over a period of two years beginning one quarter from the grant date. /s/ Anna Lucsok 2023-10-31